NEW YORK, Jan. 22, 2016 /PRNewswire/ --
GoPro Inc. (GPRO)
Lifshitz & Miller announces investigation into
possible breaches of fiduciary duties by the GPRO board.
Specifically, GPRO expects fourth quarter sales to fall 31%
annually to $435 million, well below
its prior forecast for a 13% to 21% decline. Full-year sales are
expected to rise 16% annually to $1.6
billion, down from 41% growth in fiscal 2014.
For more information about our investigation, please complete
the Information Request Form or contact Joshua Lifshitz, Esq. by
telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
Iconix Brand Group (ICON)
Lifshitz & Miller announces investigation into
possible breaches of fiduciary duties by the ICON board. On
December 28, 2015, ICON announced it
has received a formal order of investigation from the SEC. On
November 5, 2015, ICON announced it
would slash guidance for the full-year 2015, and revealed it would
restate financial results for the fiscal years 2013-2015.
For more information about our investigation, please complete
the Information Request Form or contact Joshua Lifshitz, Esq. by
telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
Inland Real Estate Corporation (IRC)
Lifshitz & Miller announces investigation into
possible breaches of fiduciary duties by the board in connection
with the proposed sale of IRC to Funds Managed by DRA Advisors LLC
at $10.60 per share.
For more information about our investigation, please complete
the Information Request Form or contact Joshua Lifshitz, Esq. by
telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
Nobilis Health Corp. (HLTH)
Lifshitz & Miller announces investigation into
possible breaches of fiduciary duties by the HLTH board. The
investigation relates to whether Nobilis's financial statements
contained numerous errors concerning the Company's classification
of warrants and options, business combination accounting,
share-based compensation, and other financial and operating
results.
For more information about our investigation, please complete
the Information Request Form or contact Joshua Lifshitz, Esq. by
telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
Sarepta Therapeutics, Inc. (SRPT)
Lifshitz & Miller announces investigation on behalf of
investors of SRPT. Specifically, the FDA contends the data
does not make a convincing case that eteplirsen works in the target
patient group or that it accomplishes what it was designed to
do.
For more information about our investigation, please complete
the Information Request Form or contact Joshua Lifshitz, Esq. by
telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
Synutra International Inc. (SYUT)
Lifshitz & Miller announces investigation into
possible breaches of fiduciary duties by the board in connection
with the "going-private" offer by the SYUT Chairman and CEO and his
affiliated entity to purchase Syut for $5.91 per share.
For more information about our investigation, please complete
the Information Request Form or contact Joshua Lifshitz, Esq. by
telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
Wilshire Bancorp Inc. (WIBC)
Lifshitz & Miller announces investigation into
possible breaches of fiduciary duties by the board in connection
with the proposed sale of WIBC to BBCN Bancorp, Inc. valued at
approximately $13.00 per share.
For more information about our investigation, please complete
the Information Request Form or contact Joshua Lifshitz, Esq. by
telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
ATTORNEY ADVERTISING. © 2016 Lifshitz &
Miller. The law firm responsible for this advertisement is
Lifshitz & Miller, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel:
(516)493-9780. Prior results do not guarantee or predict a
similar outcome with respect to any future matter.
Contact:
Joshua M. Lifshitz,
Esq.
Lifshitz & Miller
Phone:
516-493-9780
Facsimile: 516-280-7376
Email:
info@jlclasslaw.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/lifshitz--miller-law-firm-announces-investigation-of-gopro-inc-iconix-brand-group-inland-real-estate-corporation-nobilis-health-corp-sarepta-therapeutics-inc-synutra-international-inc-and-wilshire-bancorp-inc-300208497.html
SOURCE Lifshitz & Miller Law Firm